Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sablomin
- Development stage
- Unknown
- Lead developer
- Vanprom Lifesciences
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Sablomin is an oral nutritional supplement marketed by Vanprom Lifesciences. It is formulated as a tablet containing a combination of lycopene, L-lysine, zinc, potassium iodide, and essential vitamins (including vitamin A, thiamine, riboflavin, pyridoxine, niacinamide, cyanocobalamin, and ascorbic acid). Sablomin is used to support overall health, boost immunity, and manage nutritional deficiencies, anemia, and Hartnup disease. The B-complex vitamins in the formulation support healthy nerve function and help alleviate neuropathic pain, while lycopene and vitamin C act as antioxidants to protect cells from oxidative damage.
- Brand names
- Sablomin
- Other names
- Sablomin Tablet
Beyond the preview
Go deeper on Sablomin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sablomin.